What epinephrine volume (mL) should be administered intramuscularly for anaphylaxis based on patient weight, including pediatric and adult maximum limits?

Epinephrine Dosing for Anaphylactic Shock

For adults and children ≥30 kg, administer 0.3–0.5 mL of 1:1000 epinephrine (0.3–0.5 mg) intramuscularly into the anterolateral thigh; for children <30 kg, give 0.01 mg/kg (0.01 mL/kg) up to a maximum of 0.3 mL, repeated every 5–10 minutes as needed until symptoms resolve. 1

Weight-Based Dosing Algorithm

Adults and Children ≥30 kg (66 lbs)

• Administer 0.3–0.5 mL of 1:1000 epinephrine solution (0.3–0.5 mg) intramuscularly into the anterolateral aspect of the thigh. 1
• The typical adult dose is 0.5 mL (0.5 mg), which represents the maximum single injection for adults. 2
• Repeat every 5–10 minutes as necessary until anaphylaxis symptoms resolve. 1

Children <30 kg (66 lbs)

• Calculate dose as 0.01 mg/kg (0.01 mL/kg) of 1:1000 epinephrine, with a maximum single dose of 0.3 mg (0.3 mL). 1
• Administer intramuscularly into the anterolateral thigh every 5–10 minutes as needed. 1

Age-Based Dosing (Alternative Framework)

• Pediatric patients >12 years: 500 mcg (0.5 mL) IM, or 300 mcg (0.3 mL) if the child is small. 2
• Pediatric patients 6–12 years: 300 mcg (0.3 mL) IM. 2
• Pediatric patients up to 6 years: 150 mcg (0.15 mL) IM. 2

Specific Pediatric Example (10 kg child)

• For a child weighing approximately 10 kg, administer 0.1 mg (0.1 mL of 1:1000 solution) intramuscularly, repeated every 5–10 minutes until symptoms resolve. 3

Administration Technique

• Inject into the anterolateral aspect of the mid-thigh (vastus lateralis muscle)—this is the preferred site for all patients. 3, 1
• The injection may be given through clothing if needed in emergency situations. 3
• Never inject into buttocks, digits, hands, or feet due to risk of tissue necrosis and delayed absorption. 1
• The intramuscular thigh route achieves peak plasma concentrations in approximately 8 ± 2 minutes, compared with 34 ± 14 minutes for subcutaneous deltoid injection. 3

Repeat Dosing Strategy

• Multiple doses are frequently required in severe hypotension or bronchospasm. 2
• Repeat the same dose every 5–15 minutes as needed until symptoms resolve. 2
• No maximum number of doses exists; continue administering based on clinical response. 2, 3
• Symptom recurrence after 5–15 minutes is commonly reported, necessitating additional doses. 2

Concentration and Formulation

• Use 1:1000 (1 mg/mL) epinephrine for intramuscular or subcutaneous injection. 3, 1
• The 1:10,000 (0.1 mg/mL) concentration is reserved exclusively for intravenous use by experienced providers only. 3

Escalation to Intravenous Epinephrine

• If the patient does not respond to multiple intramuscular doses, consider transitioning to an intravenous epinephrine infusion. 2
• IV dosing: Start with 1 mcg/kg (one-tenth of 10 mcg/kg) and titrate to response, as children often respond to as little as 1 mcg/kg. 2
• Alternatively, initiate an IV infusion at 0.1–1.0 µg/kg/min, titrated to effect. 3
• Continuous hemodynamic monitoring is required for IV epinephrine, and it should be administered only by experienced providers in specialist settings. 2, 3

Critical Safety Considerations

• Epinephrine is the only first-line therapy for anaphylaxis; antihistamines and corticosteroids are adjuncts only. 3
• Delayed epinephrine administration is linked to fatal outcomes; administer immediately upon recognition of anaphylaxis. 3, 4, 5
• No absolute contraindication exists for epinephrine use in anaphylaxis, even in patients with cardiovascular disease. 3, 1
• The presence of sulfite in epinephrine products should not deter use for anaphylaxis. 1

Common Pitfalls and Caveats

• Do not substitute subcutaneous for intramuscular administration—IM injection produces more rapid and reliable plasma concentrations. 5
• Do not use epinephrine inhalation as a substitute for injection in children; most cannot inhale sufficient doses to achieve therapeutic plasma levels. 6
• Avoid standing or walking the patient after epinephrine administration; position supine with legs elevated to reduce mortality risk. 3
• Patients with underlying heart disease, hyperthyroidism, Parkinson's disease, diabetes, or pheochromocytoma are at greater risk for adverse reactions but should still receive epinephrine for anaphylaxis. 1

Autoinjector Considerations for Small Children

• A 0.1 mg autoinjector is now available and provides the most accurate dosing for a 10 kg child. 3
• The 0.15 mg autoinjector is commonly prescribed for children 10–25 kg, representing a 1.5-fold overdose for a 10 kg infant, but the speed and reliability may outweigh dosing inaccuracy compared with ampule-syringe techniques. 7, 3
• For children weighing approximately 25 kg (55 lbs), switching from the 0.15 mg to the 0.30 mg autoinjector is appropriate to avoid underdosing. 7

Adjunctive Medications (After Epinephrine)

• H1 antihistamine (diphenhydramine): 1–2 mg/kg (maximum 50 mg) may be given after epinephrine as adjunctive therapy. 3
• Chlorphenamine: 10 mg IV/IM for adults; 5 mg for ages 6–12 years; 2.5 mg for ages 6 months–6 years; 250 mcg/kg for <6 months. 2
• Hydrocortisone: 200 mg IV/IM for adults; 100 mg for ages 6–12 years; 50 mg for ages 6 months–6 years; 25 mg for <6 months. 2
• Never administer antihistamines or corticosteroids alone without epinephrine in anaphylaxis. 3

Post-Treatment Management

• Transfer all patients to an appropriate critical care area for observation. 2
• Provide supplemental oxygen and obtain intravenous access for fluid resuscitation if indicated. 3
• Obtain mast cell tryptase levels: initial sample during resuscitation, second at 1–2 hours, third at 24 hours or in convalescence. 2
• Refer all patients to an allergy specialist for identification of trigger and long-term management. 2